1 Min Read
Jan 16 (Reuters) - Sinclair IS Pharma PLC : * Revenues for H1 expected to be approximately £24.5 million (£23.0 million H1
FY 2013) * Strong H2 expected to produce c7% lfl growth
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.